Latest Franchising News

Harvey Norman Holdings Limited reported strong FY25 financial results, driven by growth in franchisee sales, property portfolio appreciation, and digital investments. The company’s integrated retail, franchise, property, and digital system across multiple countries underpins its sustained shareholder returns.

The Agency Group has delivered a record financial performance in FY2025, with Gross Commission Income surpassing $125 million, driven by strong growth in residential sales and property management. The company’s unique national direct agency model and strategic expansion into emerging markets underpin its positive outlook.

Tetratherix Limited advances its Tetramatrix biomaterial platform with a robust IP portfolio, scalable manufacturing, and strategic partnerships aimed at commercialising across multiple clinical franchises.

Tetratherix Limited reports its first financial results as a listed company, revealing a $9.4 million statutory loss driven by R&D and listing costs, alongside a robust $29.3 million cash position post-IPO. The company highlights key operational milestones and outlines strategic plans to accelerate commercialisation across its innovative biomaterial platform.

Tetratherix Limited reported a $9.4 million statutory loss for FY25 amid significant R&D and operational investments, successfully listing on the ASX and progressing multiple clinical and manufacturing initiatives.

Domino’s Pizza Enterprises reported a modest dip in FY25 sales and earnings amid a strategic reset focused on cost efficiency and franchisee support. The company aims to rebuild momentum through targeted reinvestment and operational simplification.

Domino’s Pizza Enterprises Limited reported a statutory net loss for FY25, closing 312 underperforming stores and navigating significant leadership changes while declaring an unfranked final dividend.

Sigma Healthcare reports a robust FY25 performance post-merger with Chemist Warehouse Group, delivering strong revenue growth and upgraded synergy targets. The company signals continued expansion and efficiency gains heading into FY26.

Sigma Healthcare has completed a reverse acquisition merger with Chemist Warehouse, reporting $6 billion in revenue and declaring a fully franked dividend. The merger reshapes Australia’s pharmacy landscape with ambitious synergy targets and operational shifts.

Cash Converters International Limited reported robust FY25 results, driven by strategic franchise acquisitions and a shift to longer-term, lower-cost lending products. The company is poised for further growth with new loan launches and luxury retail expansion.

Cash Converters International Limited reports a robust 41% increase in statutory net profit for FY2025, driven by a strategic transformation that includes exiting payday lending, expanding luxury retail, and growing its franchise footprint in Australia and the UK.

Cash Converters International Limited reported a robust 41% increase in net profit for FY2025, driven by strategic franchise acquisitions and a shift in loan product mix. The company declared a fully franked final dividend and maintains a strong balance sheet as it navigates evolving regulatory and market conditions.